Advances in artificial intelligence in drug delivery and development: A comprehensive review

AD Gholap, MJ Uddin, M Faiyazuddin, A Omri… - Computers in Biology …, 2024 - Elsevier
Artificial intelligence (AI) has emerged as a powerful tool to revolutionize the healthcare
sector, including drug delivery and development. This review explores the current and future …

Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery

MK Tripathi, A Nath, TP Singh, AS Ethayathulla… - Molecular Diversity, 2021 - Springer
The accumulation of massive data in the plethora of Cheminformatics databases has made
the role of big data and artificial intelligence (AI) indispensable in drug design. This has …

Enhanced-sampling simulations for the estimation of ligand binding kinetics: current status and perspective

K Ahmad, A Rizzi, R Capelli, D Mandelli… - Frontiers in molecular …, 2022 - frontiersin.org
The dissociation rate (k off) associated with ligand unbinding events from proteins is a
parameter of fundamental importance in drug design. Here we review recent major …

Yes SIR! On the structure–inactivity relationships in drug discovery

E López-López, E Fernández-de Gortari… - Drug Discovery …, 2022 - Elsevier
Highlights•Inactivity data is helpful.•Structure-Inactivity Relationships (SIRs) are valuable in
drug discovery.•Machine and deep learning benefit from SIRs.•The inactivity data gap in the …

De novo drug design using reinforcement learning with multiple gpt agents

X Hu, G Liu, Y Zhao, H Zhang - Advances in Neural …, 2023 - proceedings.neurips.cc
De novo drug design is a pivotal issue in pharmacology and a new area of focus in AI for
science research. A central challenge in this field is to generate molecules with specific …

Advances in ultra-high-resolution mass spectrometry for pharmaceutical analysis

E Deschamps, V Calabrese, I Schmitz, M Hubert-Roux… - Molecules, 2023 - mdpi.com
Pharmaceutical analysis refers to an area of analytical chemistry that deals with active
compounds either by themselves (drug substance) or when formulated with excipients (drug …

Machine learning in antibacterial drug design

M Jukič, U Bren - Frontiers in Pharmacology, 2022 - frontiersin.org
Advances in computer hardware and the availability of high-performance supercomputing
platforms and parallel computing, along with artificial intelligence methods are successfully …

Machine learning in Alzheimer's disease drug discovery and target identification

C Geng, ZB Wang, Y Tang - Ageing Research Reviews, 2024 - Elsevier
Alzheimer's disease (AD) stands as a formidable neurodegenerative ailment that poses a
substantial threat to the elderly population, with no known curative or disease-slowing drugs …

Digital technology applications in the management of adverse drug reactions: bibliometric analysis

O Litvinova, AWK Yeung, FP Hammerle, ME Mickael… - Pharmaceuticals, 2024 - mdpi.com
Adverse drug reactions continue to be not only one of the most urgent problems in clinical
medicine, but also a social problem. The aim of this study was a bibliometric analysis of the …

Intermolecular interactions between nitrosourea and polyoxometalate compounds

MD Mohammadi, F Abbas, H Louis… - …, 2022 - Wiley Online Library
Herein, the aim of this work was to investigate the intermolecular interactions between
polyoxometalate (POMs) as a drug‐delivery system with nitrosourea at different sites: CH3 …